Apeloa Pharmaceutical Co Ltd (000739) - Total Assets
Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) holds total assets worth CN¥12.10 Billion CNY (≈ $1.77 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 000739 book value for net asset value and shareholders' equity analysis.
Apeloa Pharmaceutical Co Ltd - Total Assets Trend (1994–2024)
This chart illustrates how Apeloa Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.
Apeloa Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Apeloa Pharmaceutical Co Ltd's total assets of CN¥12.10 Billion consist of 64.3% current assets and 35.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 28.8% |
| Accounts Receivable | CN¥2.35 Billion | 18.5% |
| Inventory | CN¥1.86 Billion | 14.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥314.61 Million | 2.5% |
| Goodwill | CN¥20.31 Million | 0.2% |
Asset Composition Trend (1994–2024)
This chart illustrates how Apeloa Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Apeloa Pharmaceutical Co Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apeloa Pharmaceutical Co Ltd's current assets represent 64.3% of total assets in 2024, an increase from 48.5% in 1994.
- Cash Position: Cash and equivalents constituted 28.8% of total assets in 2024, up from 4.2% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.
Apeloa Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Apeloa Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Apeloa Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.43 | 1.36 | 1.70 |
| Quick Ratio | 1.13 | 1.07 | 1.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.27 Billion | CN¥2.31 Billion | CN¥2.02 Billion |
Apeloa Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Apeloa Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -0.3% |
| Total Assets | CN¥12.73 Billion |
| Market Capitalization | $3.10 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Apeloa Pharmaceutical Co Ltd's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Apeloa Pharmaceutical Co Ltd's assets decreased by 0.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Apeloa Pharmaceutical Co Ltd (1994–2024)
The table below shows the annual total assets of Apeloa Pharmaceutical Co Ltd from 1994 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥12.73 Billion ≈ $1.86 Billion |
-0.30% |
| 2023-12-31 | CN¥12.77 Billion ≈ $1.87 Billion |
+6.25% |
| 2022-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+31.14% |
| 2021-12-31 | CN¥9.16 Billion ≈ $1.34 Billion |
+22.26% |
| 2020-12-31 | CN¥7.49 Billion ≈ $1.10 Billion |
+14.91% |
| 2019-12-31 | CN¥6.52 Billion ≈ $954.46 Million |
+13.42% |
| 2018-12-31 | CN¥5.75 Billion ≈ $841.52 Million |
+1.05% |
| 2017-12-31 | CN¥5.69 Billion ≈ $832.79 Million |
+1.28% |
| 2016-12-31 | CN¥5.62 Billion ≈ $822.23 Million |
+4.15% |
| 2015-12-31 | CN¥5.39 Billion ≈ $789.45 Million |
+6.58% |
| 2014-12-31 | CN¥5.06 Billion ≈ $740.70 Million |
+8.57% |
| 2013-12-31 | CN¥4.66 Billion ≈ $682.23 Million |
+13.51% |
| 2012-12-31 | CN¥4.11 Billion ≈ $601.02 Million |
+99.21% |
| 2011-12-31 | CN¥2.06 Billion ≈ $301.70 Million |
+11.77% |
| 2010-12-31 | CN¥1.84 Billion ≈ $269.92 Million |
+5.42% |
| 2009-12-31 | CN¥1.75 Billion ≈ $256.03 Million |
+0.49% |
| 2008-12-31 | CN¥1.74 Billion ≈ $254.78 Million |
+7.87% |
| 2007-12-31 | CN¥1.61 Billion ≈ $236.20 Million |
+25.67% |
| 2006-12-31 | CN¥1.28 Billion ≈ $187.96 Million |
+12.19% |
| 2005-12-31 | CN¥1.14 Billion ≈ $167.53 Million |
+2.73% |
| 2004-12-31 | CN¥1.11 Billion ≈ $163.08 Million |
+29.13% |
| 2003-12-31 | CN¥863.07 Million ≈ $126.29 Million |
+25.21% |
| 2002-12-31 | CN¥689.28 Million ≈ $100.86 Million |
+17.35% |
| 2001-12-31 | CN¥587.38 Million ≈ $85.95 Million |
+7.46% |
| 2000-12-31 | CN¥546.58 Million ≈ $79.98 Million |
+5.05% |
| 1999-12-31 | CN¥520.33 Million ≈ $76.14 Million |
+9.50% |
| 1998-12-31 | CN¥475.19 Million ≈ $69.54 Million |
+49.78% |
| 1997-12-31 | CN¥317.25 Million ≈ $46.42 Million |
+93.01% |
| 1996-12-31 | CN¥164.37 Million ≈ $24.05 Million |
+12.36% |
| 1995-12-31 | CN¥146.29 Million ≈ $21.41 Million |
+3.38% |
| 1994-12-31 | CN¥141.51 Million ≈ $20.71 Million |
-- |
About Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates serie… Read more